news28 September 2017 | By Dr Zara Kassam (European Pharmaceutical Review)
Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the EC has granted marketing authorisation for Dupixent for use in adults with moderate-to-severe atopic dermatitis...